79345867 - RECOMBUMIN

Information

• Trademark
• 79345867

• Source

• Serial Number

  79345867

• Registration Number

  7362015

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  May 26, 2022
  4 years ago

• Registration Date

  April 23, 2024
  2 years ago

• Transaction Date

  May 08, 2025
  a year ago

• Status Date

  April 23, 2024
  2 years ago

• Published for Opposition Date

  February 06, 2024
  2 years ago

• Location Date

  April 23, 2024
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  PERKINS, ELLEN

• Attorney Docket Number

  ALBU 2308202

  Attorney Name

  Karen Lim

  Law Office Assigned Location Code

  M10

• Owners

  • ALBUMEDIX LTD

Case File Statements

• GS0051: Pharmaceuticals for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; pharmaceutical products and substances for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; albumin, chemical preparations, synthetic peptides, protein supplements, monoclonal, polyclonal, immunological, native and recombinant antibodies for medical and veterinary use, cells for medical and veterinary use, viruses, live viruses, live- attenuated viruses, attenuated viruses, and virus-like particles and viral vectors for medical and veterinary use, vaccines, growth factors for medical and veterinary use, immune modulators for medical and veterinary use, monoclonal antibodies, biological tissue and tissue cultures, recombinant proteins for medical and veterinary use, nucleic acid sequences, blood plasma, blood components for medical and veterinary use, all being for pharmaceutical use for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; reagents for medical use; diagnostic reagents for medical use; protein supplements for pharmaceutical purposes; albuminous preparations for medical or veterinary purposes; recombinant albumin for biological therapeutic purposes
• GS0011: Chemicals used in industry, science and for use in the manufacture of pharmaceuticals; chemical reagents other than for medical or veterinary purposes; diagnostic reagents and preparations, other than for medical or veterinary purposes; chemical excipients for use in the manufacture of pharmaceutical preparations; proteins for industrial purposes; recombinant human albumin for use as a stabilizer and excipient for industrial purposes and for use in the manufacture of cell culture media, cell and tissue storage and preservation media and for the manufacture of diagnostic imaging agents; cell culture reagents for scientific and research use, and chemical preservation reagents for scientific and research use; albumin for use in the manufacture of pharmaceutical products, vaccines, cellular therapies, regenerative medicines and gene therapies; protein in raw material form for scientific and medical research

Case File Event Statements

• 8/2/2022 - 4 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 7/21/2022 - 4 years ago

  1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC

• 7/27/2022 - 4 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 7/29/2022 - 4 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/29/2023 - 3 years ago

  5 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 3/7/2023 - 3 years ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 3/15/2023 - 3 years ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/16/2023 - 3 years ago

  8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/2/2023 - 3 years ago

  9 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 5/3/2023 - 3 years ago

  10 - REFUSAL PROCESSED BY MPU Type: RFRR

• 5/3/2023 - 3 years ago

  11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 5/23/2023 - 3 years ago

  12 - REFUSAL PROCESSED BY IB Type: RFNT

• 11/3/2023 - 2 years ago

  13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/3/2023 - 2 years ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/3/2023 - 2 years ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/27/2023 - 2 years ago

  17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 12/27/2023 - 2 years ago

  16 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 12/31/2023 - 2 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/17/2024 - 2 years ago

  22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/17/2024 - 2 years ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/17/2024 - 2 years ago

  21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 2/5/2024 - 2 years ago

  23 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 2/6/2024 - 2 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/6/2024 - 2 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/13/2024 - 2 years ago

  19 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 4/23/2024 - 2 years ago

  26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 4/23/2024 - 2 years ago

  27 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 7/24/2024 - 2 years ago

  28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 10/23/2024 - a year ago

  29 - FINAL DISPOSITION PROCESSED Type: FIMP

• 10/23/2024 - a year ago

  30 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 11/9/2024 - a year ago

  31 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 4/11/2025 - a year ago

  32 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 4/16/2025 - a year ago

  34 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 4/16/2025 - a year ago

  36 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 4/16/2025 - a year ago

  37 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 4/16/2025 - a year ago

  35 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/16/2025 - a year ago

  33 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR